Target intelligence / Profile preview

RNA, U6 small nuclear 194, pseudogene (RNU6-194P)

Target
RNU6-194P
Molecular classification
Pseudogene, Non-coding RNA (snRNA pseudogene), Other (does not fit classical target types like enzyme, receptor, transporter)
01

Overview

RNU6-194P, or RNA, U6 small nuclear 194, pseudogene, is a classified pseudogene of the human genome encoding a sequence similar to that of U6 small nuclear RNA (snRNA), which normally participates in the spliceosome complex and pre-mRNA splicing. In vertebrate genomes, U6 snRNA pseudogenes are numerous and do not encode functional proteins or RNAs. Pseudogenes like RNU6-194P generally arise from retrotransposition or duplication of snRNA genes; they are commonly transcriptionally inactive and considered "genomic fossils," though some pseudogenes may exert regulatory effects on their parental genes or other RNAs through mechanisms such as acting as miRNA decoys or producing regulatory non-coding RNAs[3][4]. However, there is no literature evidence that RNU6-194P itself is functional, clinically relevant, or a validated molecular target for drug discovery or therapy in humans.

Other names
RNU6-194PRNA, U6 small nuclear 194, pseudogeneU6-194P (constructed alias)U6 small nuclear RNA pseudogene 194
02

Mechanism of action

None

03

Biological functions

Other (Pseudogenes generally lack protein-coding function; some may have regulatory or RNA decoy roles but none established for RNU6-194P specifically)Related to non-coding RNA gene families
04

Disease associations

Other (There is no direct evidence linking RNU6-194P with specific diseases; generally, some pseudogenes have regulatory effects in cancer, but no evidence found for this one)

Beyond the preview

Go deeper on RNA, U6 small nuclear 194, pseudogene (RNU6-194P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 194, pseudogene (RNU6-194P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call